Charly got excited about shares while working in a research lab as a grad student and seeing biotech stocks go crazy during the heyday of the human genome project. His love for investing quickly spread to other industries, and it was not a hard choice to trade in the lab coat for a business calculator after being bitten by one too many lab rats. He is a novice home brewer who hopes to one day cook up something worth drinking ... and to not lose the recipe.
Charly has worn many hats at the Fool, including writer, analyst, and head of the biotech and pharmaceutical sectors. Charly employs diverse investing styles ranging from buying cheap shares that have temporarily fallen out of favour to buying shares of high quality growth companies that he expects to hold for many years to benefit from long-term capital appreciation.
For the past four years Charly has co-managed Motley Fool Million Dollar Portfolio, a US service that invests The Motley Fool's money into the best share ideas from across the Fool. He has years of stock picking behind him as an analyst on the Rule Breakers, Hidden Gems, and Pay Dirt services in the US.
Charly earned a B.A. in psychology from Illinois Wesleyan University and an M.S. in pharmacological and physiological sciences from St. Louis University. In the course of his studies, he conducted research on animal models of Alzheimer's disease and the molecular mechanisms of cell growth.